Senior Care Pharmacy Coalition Releases Statement on New Congressional Letter Regarding ESI Contracts
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today in response to the recent letter to Assistant Secretary Martinez-Lopez and Lieutenant General Crosland regarding Express Scripts (ESI) contracts within TRICARE:
“We commend Senator Warren, Representative Carter and the 22 bipartisan co-signers of the recent letter to the Defense Health Agencyvoicing concerns with the decision to contract with Cigna-owned Express Scripts (ESI) – one of the largest PBMs in the country – to administer TRICARE’s pharmacy program.
“Since the shift to ESI in 2022, ESI has leveraged its market power to steer the 9.6 million TRICARE beneficiaries toward their own mail-order pharmacies. They deny and overcharge for critical health care while inadequately reimbursing the long-term care (LTC) pharmacies that provide specialized services to our active-duty service members, family members, and military retirees.
“This year, ESI has brought the same predatory practices to millions of Medicare Part D beneficiaries living in LTC facilities, especially low-income beneficiaries dually eligible for both Medicare and Medicaid. The result: inferior care for seniors and financial challenges for LTC pharmacies, all so ESI and its affiliated mail-order pharmacy can rake in even more money. This problem only underscores the pressing need for comprehensive PBM reform.
“We urge Congress to take action to hold ESI accountable for its predatory and anticompetitive practices. This is crucial to ensure that TRICARE beneficiaries – and all Americans who rely on LTC pharmacy services – can continue to receive quality care, especially the unique services offered by LTC pharmacies,” said Alan Rosenbloom, President and CEO of SCPC.
###
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.